Speakers 2017

The following speakers will lecture at PharmaLab 2017:

• Ulla Bondegaard, Novo Nordisk, Bagsværd, Denmark
  Currently responsible for maintaining cross-organisational (and cross-country) laboratory processes.
• Peter J. Boogaard, Industrial Lab Automation, The Netherlands
  Founder Industrial Lab Automation. Member of the ISPE GAMP community.
• Dr Susan Brand-Hoefs, MSD, The Netherlands
  Microbiologist
• Peter Cornelis, Toxikon, Belgium
  R&D scientist and Business Analyst.
• Dr Ruth Daniels, Janssen, Belgium
  Senior Scientist, SME micro. Member of BPOG Low endotoxin recovery Group, and PDA Low endotoxin recovery task force
• Dr Anja Fritsch, Confarma, France
  Responsible for cell based bioassays (development and routine).
• Dr Wolf-Christian Gerstner, Geniu, Hamburg
  Managing Director
• Prof. Edwin van den Heuvel, University of Technology, Eindhoven, The Netherlands
  Professor at the TU/e department of Mathematics and Computer Science; professor Medical Statistics at the UMCG (University Medical Center Groningen).
• Dr Sunhee Hong, Charles River Microbial Solutions, USA
  Senior Staff Scientist. Responsible for curating the bacterial and protein coding gene sequence libraries for the Accugenix ID services.
• Marleen Hoozemans, MSD, The Netherlands
  Currently working on the development of the Rapid Hybrid Mycoplasma Method.
• Dr Patricia Hughes, U.S. Food and Drug Administration
  Branch Chief (Actg), Division of Microbiology Assessment, OPF/ OPQ/ CDER.
• Pieta IJzerman-Boon, MSD, the Netherlands
  Associate Director Quantitative Sciences/Center for Mathematical Sciences-Europe
• Rick Jakober, Perritt Laboratories, Inc., USA
  Vice President Laboratory Services. Over 35 years experience in pharmaceutical microbiology, specializing in non-sterile products.
• Niek Janssen, ALTRAN Netherlands
  Senior Consultant Life Sciences with strong background Computerised System Validation (CSV) and Industrial IT.
• Dr Sébastien Jouette, EDQM, Strasbourg, France
  Scientific programme officer in the Biological Division of the European Pharmacopoeia department.
• Kham Nguyen, Rapid Micro Biosystems, USA
  Director of Sales.
• Jan-Oliver Karo, Paul-Ehrlich-Institut – German Federal Institute for Vaccines and Biomedicines
  Associate Director Quantitative Sciences/Center for Mathematical Sciences-Europe
• Leo Leineweber, Technical Auditor/ Inspector, Münster, Germany
  Head of laboratory within the Official Medicines Control Laboratory (OMCL) located at the NRW Centre for Health of the federal state Nordrhein-Westfalen.
• Dr Lars Lueersen, CSL Behring Recombinant Facility AG Bern, Switzerland
  Senior Manager Chemical Quality Control und Global Tech Transfer PM.
• Robert Lutskus, Lonza, USA
  Global Product Delivery Manager for MODA™ EM.
• Eric De Maesschalck, UCB, Belgium
  Head of Global e-Analytics, Corporate Analytical Sciences.
• Marine Marius, Sanofi Pasteur, France
  Leads RMM implementation in ARD Eu for mycoplasma and endotoxin testing
• Dr Alexandra Müller-Scholz, Sartorius-Stedim-Biotech, Germany
  Scientist R&D Microbiology department
• Dr Danilo Neri, PQE, Italy
  Validation Project Manager with expertise on Computer System Validation.
• Dr Karen Nordgren, National Institute of Standards and Control (NIBSC), United Kingdom
  Head of the Pyrogen Science Group, responsible for BET and MAT testing at the Institute, as well as maintaining established and developing new standards to support the area.
• Robert Porzio, Lonza, USA
  Global Product Manager. Focusing in instrumentation, automation and software solutions.
• Dr Jan Erik Rau, Lonza, Switzerland
  Senior Scientist and Lab-Manager.
• Dr Johannes Reich, MicroCoat Biotechnologie GmbH, Germany
  Focus on the aggregation and interaction of Lipopolysaccharides as well as the related activities in limulus based detection Systems.
• Dr Michael Rieth, Merck, Germany
  Department Global Regulatory Affairs
• Dr David Roesti, Novartis Pharma Stein/USP, Switzerland
  Head of the RMM team and the Novartis Pharma expert network in microbiology.
• Donald C. Singer, GSK/USP, USA
  GSK Senior Fellow / Biopharmaceutical GMP Ops at GSK. Vice-Chair of the USP Microbiology Committee of Experts.
• Dr Klára Sochorová, Sotioa.s., Czech Republic
  Working in cell therapy area. Particpates in the development from the scientific concept to the medicinal product used in phase III study.
• Shabnam Solati, MAT Research, The Netherlands
  Biomolecular Researcher with 25 years of experience, and Monocyte Activation Test (MAT) specialist for over 11 years.
• Dr Ingo Spreitzer, Paul-Ehrlich-Institut, Germany Agency for Vaccines and Biomedicines
  Deputy Head of Section 1/3, “Microbial Safety and Parasitology”.
• Dr Radhakrishna Tirumalai, USP, USA
  Global Principal Scientific Liaison-General Chapters in the Science Division. Liaison to the USP Expert Committee on Microbiology.
• Dr Ruud Vervoort, Waters, The Netherlands
  European Informatics Business Development Manager.
• Dr Astrid Visser, Sanquin Blood Supply Foundation, The Netherlands
  Coordinates the development of the MAT assay and cells for a robust, reliable Assay
• Kevin Williams, BioMerieux, USA
  Author of the book “EndotoxinS 2”.
• Dr Friedrich von Wintzingerode, Roche Diagnostics GmbH
  Senior Manager Microbiology, Head of Roche/Genentech global Endotoxin Expert Group and Roche/Genentech global SME on microbial product contaminations.
• Dr Carl-Ulrich Zimmermann, Mycoplasma Biosafety Services, Vienna, Austria
  Head of Research and Development.